RRR (95% CI, p value) of serum vitamin K1 status with microangiopathic and macroangiopathic status among individuals with and without diabetes
| N | RRR | (95% CI) | P value | |
| Individuals with diabetes | ||||
| Crude model (n=3239) | ||||
| Only microangiopathy | 349 | 1.05 | (0.98 to 1.12) | 0.180 |
| Only macroangiopathy | 263 | 0.89 | (0.77 to 1.03) | 0.115 |
| Microangiopathy and macroangiopathy | 109 | 1.05 | (0.96 to 1.15) | 0.305 |
| Unspecified | 858 | 1.03 | (0.98 to 1.09) | 0.273 |
| Adjusted model* (n=3122) | ||||
| Only microangiopathy | 337 | 1.10 | (1.01 to 1.19) | 0.022 |
| Only macroangiopathy | 252 | 0.79 | (0.66 to 0.96) | 0.016 |
| Microangiopathy and macroangiopathy | 107 | 1.05 | (0.91 to 1.22) | 0.507 |
| Unspecified | 815 | 1.06 | (0.98 to 1.14) | 0.132 |
| Individuals without diabetes | ||||
| Crude model (n=3808) | ||||
| Only microangiopathy | 113 | 1.03 | (0.96 to 1.11) | 0.418 |
| Only macroangiopathy | 262 | 1.04 | (0.99 to 1.10) | 0.086 |
| Microangiopathy and macroangiopathy | 29 | 0.63 | (0.33 to 1.20) | 0.163 |
| Adjusted model* (n=3699) | ||||
| Only microangiopathy | 111 | 1.05 | (0.95 to 1.17) | 0.331 |
| Only macroangiopathy | 257 | 1.08 | (0.98 to 1.19) | 0.106 |
| Microangiopathy and macroangiopathy | 27 | 0.75 | (0.38 to 1.47) | 0.395 |
*Age at enrollment, body mass index, HbA1c, systolic blood pressure, low-density lipoprotein, triglycerides, estimated glomerular filtration rate, waist:hip ratio (within/above recommendations), gender, smoking status, alcohol (below/above recommended limit).
RRR, relative risk ratio.